AHealthyMe
-
Login Registration Sample personal Change Profile Log Out
Search AHealthyMe!  
Personalize AHealthyMe! -Sign up for our Newsletter!

Women's HealthMen's HealthHelath After 60Children's HealthPregnancyFitness & NutritionAlternative HealthLifestyle & WellnessWork & HealthIlls & ConditionsDental HealthSelf-Care CentersMedical LibraryCool ToolsMultimediaEn Español-

Blue Cross Blue Shield of Massachusetts

You are here: Home > Health A to Z > IgA nephropathy



IgA nephropathy

Definition
Treatment
Alternative Names
Support Groups
Causes, incidence, and risk factors
Expectations (prognosis)
Symptoms
Complications
Signs and tests
Calling your health care provider


Male urinary system
Male urinary system

 Definition  

IgA nephropathy is a kidney disorder characterized by blood in the urine. It is caused by inflammation of internal kidney structures and the deposit of IgA antibodies in kidney tissue.

It is also called Berger's disease.

 Alternative Names  

Nephropathy - IgA; Berger's disease

 Causes, incidence, and risk factors  

IgA nephropathy (Berger's disease) is a form of mesangial proliferative nephritis. It occurs when abnormal deposits of immunoglobin A build up inside the small blood vessels of the kidney. Structures in the kidney called glomeruli become inflamed.

The disorder can appear suddenly (acute), or progress slowly over many years (chronic glomerulonephritis).

Risk factors include having a personal or family history of IgA nephropathy or Henoch Schonlein purpura, a form of vasculitis that affects many parts of the body, and may cause a kidney lesion that is identical to the lesion of Berger's disease.

IgA nephropathy can occur in persons of all ages, but most often affects males in their teens to late 30s.

 Symptoms  

  • Changes in color of urine - bloody, dark, brown, or rust colored
  • Repeated episodes of dark or bloody urine

 Signs and tests  

IgA nephropathy usually is discovered after one or more episodes of dark or bloody urine in a person with no other symptoms of kidney disorder.

Bloody urine may begin during or soon after a respiratory infection.

There are no specific changes seen during a physical examination. Occasionally, blood pressure may be high or swelling of the body may be present.

Tests that may be done include:

  • Urinalysis
  • Kidney biopsy (confirms the diagnosis)
  • Urine immunoelectrophoresis

 Treatment  

The goal of treatment is to relieve symptoms and prevent or delay chronic renal failure.

Medicines may be given to control high blood pressure and swelling (edema). Controlling blood pressure is the most important measure to delay kidney damage.

Corticosteroids, other immunosuppressive drugs, and fish oil have also been used to treat this disorder.

Salt and fluids may be restricted to control swelling. A low to moderateprotein diet may be recommended in some cases.

 Support Groups  

For additional information and support, see the IgA Nephropathy Support Network website (www.igansupport.org).

 Expectations (prognosis)  

IgA nephropathy progresses slowly. In many cases, it does not progress at all. High blood pressure, large quantities of protein in the urine, and increased BUN or creatinine levels (blood tests that reflect kidney functioning) indicate a higher risk for progression of the disorder.

About 25% of people with IgA nephropathy develop end-stage kidney failure within about 25 years.

 Complications  

  • Acute nephritic syndrome or nephrotic syndrome
  • Chronic kidney failure
  • End-stage kidney disease

 Calling your health care provider  

Call your health care provider if you have bloody urine or if your urine output decreases.

Review date: 8/14/2007

Reviewed By: Charles Silberberg, DO, Private Practice specializing in Nephrology, Affiliated with New York Medical College, Division of Nephrology, Valhalla, NY. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.